COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection

In December 2019, a novel coronavirus, SARS-CoV-2, appeared, causing a wide range of symptoms, mainly respiratory infection. In March 2020, the World Health Organization (WHO) declared Coronavirus Disease 2019 (COVID-19) a pandemic, therefore the efforts of scientists around the world are focused on...

Descripción completa

Detalles Bibliográficos
Autores principales: Lechowicz, Kacper, Drożdżal, Sylwester, Machaj, Filip, Rosik, Jakub, Szostak, Bartosz, Zegan-Barańska, Małgorzata, Biernawska, Jowita, Dabrowski, Wojciech, Rotter, Iwona, Kotfis, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356800/
https://www.ncbi.nlm.nih.gov/pubmed/32575380
http://dx.doi.org/10.3390/jcm9061917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356800/
https://www.ncbi.nlm.nih.gov/pubmed/32575380
http://dx.doi.org/10.3390/jcm9061917

Ejemplares similares